XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.3
DERIVATIVES (Tables)
 9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Derivative Financial Instruments Included in Unaudited Condensed Consolidated Balance Sheets
The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands):
Derivatives designated as hedging instrumentsBalance Sheet LocationSeptember 30, 2025December 31, 2024
Foreign exchange contractsPrepaid expenses and other current assets$— $256 
Accrued expenses132 — 

Derivatives not designated as hedging instrumentsBalance Sheet LocationSeptember 30, 2025December 31, 2024
Interest rate swaps
Prepaid expenses and other current assets
$— $102 

Other assets
— 379 
Other long-term liabilities428 154 
Schedule of Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments
The amounts of gains and losses, realized and unrealized, related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive income, net of taxes, as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
Derivatives designated as hedging instruments2025202420252024
Foreign exchange contracts$141 $(203)$(449)$20 
Schedule of Derivatives Not Designated as Hedging Instruments
Interest and mark to market losses related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
Derivatives not designated as hedging instrumentsLocation of gain (loss)2025202420252024
Interest rate swaps
Mark to market loss on interest rate derivatives
$(8)$(928)$(755)$(1,184)
Interest expense65 298 298 828 
$57 $(630)$(457)$(356)